Shane Storey
Stock Analyst at Canaccord Genuity
(2.11)
# 3,124
Out of 4,592 analysts
343
Total ratings
45%
Success rate
0.5%
Average return
Main Sectors:
Stocks Rated by Shane Storey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: TLX Telix Pharmaceuticals Limited | Maintained: Buy | $30.00 | $14.21 | +111.12% | 55 | Jul 22, 2026 | |
| ASX: ACW Actinogen Medical Limited | Maintained: Buy | $0.08 | $0.04 | +95.12% | 5 | Jul 21, 2026 | |
| ASX: RMD ResMed Inc. | Maintained: Buy | $44.50 → $40.00 | $29.79 | +34.27% | 21 | Jul 21, 2026 | |
| NZE: FPH Fisher & Paykel Healthcare Corporation Limited | Maintained: Buy | $44.95 → $43.75 | $40.69 | +7.52% | 16 | May 27, 2026 | |
| ASX: CSL CSL Limited | Downgraded: Hold | $180.00 → $106.31 | $123.06 | -13.61% | 28 | May 12, 2026 | |
| ASX: ARX Aroa Biosurgery Limited | Maintained: Buy | $1.16 → $1.35 | $0.57 | +136.84% | 28 | May 3, 2026 | |
| ASX: COH Cochlear Limited | Maintained: Buy | $295.00 → $120.00 | $119.94 | +0.05% | 19 | Apr 29, 2026 | |
| ASX: MVF Monash IVF Group Limited | Maintained: Hold | $0.69 → $0.86 | $0.70 | +22.86% | 20 | Apr 29, 2026 | |
| ASX: OCC Orthocell Limited | Maintained: Buy | $1.33 → $1.26 | $0.73 | +72.60% | 2 | Apr 20, 2026 | |
| ASX: SOM SomnoMed Limited | Maintained: Buy | $1.00 | $0.45 | +122.22% | 22 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5.43 → $5.55 | $3.14 | +76.75% | 21 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.00 → $2.57 | $2.10 | +22.38% | 12 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.62 → $1.58 | $0.87 | +82.66% | 16 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.85 → $2.40 | $2.38 | +0.84% | 3 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.07 → $0.06 | $0.00 | +1,400.00% | 22 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $350.00 | $162.21 | +115.77% | 5 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.85 → $0.80 | $0.30 | +171.19% | 4 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $37.00 | $44.34 | -16.55% | 11 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32.84 | $9.06 | +262.47% | 3 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.00 → $2.81 | $0.29 | +868.97% | 4 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.20 | $0.05 | +2,508.70% | 2 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.00 | $1.70 | +76.47% | 3 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26.50 | $18.00 | +47.22% | 1 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8.50 | $2.37 | +258.65% | 7 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.00 | $0.01 | n/a | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5.95 → $7.40 | $2.66 | n/a | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $0.71 → $0.55 | $0.41 | n/a | 3 | Feb 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $0.17 → $0.06 | $1.16 | n/a | 2 | Sep 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $0.50 → $0.55 | $0.10 | n/a | 3 | Aug 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.75 | $0.01 | n/a | 1 | Jun 1, 2022 |
Telix Pharmaceuticals Limited
Jul 22, 2026
Maintained: Buy
Price Target: $30.00
Current: $14.21
Upside: +111.12%
Actinogen Medical Limited
Jul 21, 2026
Maintained: Buy
Price Target: $0.08
Current: $0.04
Upside: +95.12%
ResMed Inc.
Jul 21, 2026
Maintained: Buy
Price Target: $44.50 → $40.00
Current: $29.79
Upside: +34.27%
Fisher & Paykel Healthcare Corporation Limited
May 27, 2026
Maintained: Buy
Price Target: $44.95 → $43.75
Current: $40.69
Upside: +7.52%
CSL Limited
May 12, 2026
Downgraded: Hold
Price Target: $180.00 → $106.31
Current: $123.06
Upside: -13.61%
Aroa Biosurgery Limited
May 3, 2026
Maintained: Buy
Price Target: $1.16 → $1.35
Current: $0.57
Upside: +136.84%
Cochlear Limited
Apr 29, 2026
Maintained: Buy
Price Target: $295.00 → $120.00
Current: $119.94
Upside: +0.05%
Monash IVF Group Limited
Apr 29, 2026
Maintained: Hold
Price Target: $0.69 → $0.86
Current: $0.70
Upside: +22.86%
Orthocell Limited
Apr 20, 2026
Maintained: Buy
Price Target: $1.33 → $1.26
Current: $0.73
Upside: +72.60%
SomnoMed Limited
Apr 16, 2026
Maintained: Buy
Price Target: $1.00
Current: $0.45
Upside: +122.22%
Mar 4, 2026
Maintained: Buy
Price Target: $5.43 → $5.55
Current: $3.14
Upside: +76.75%
Mar 4, 2026
Maintained: Buy
Price Target: $3.00 → $2.57
Current: $2.10
Upside: +22.38%
Feb 23, 2026
Maintained: Buy
Price Target: $1.62 → $1.58
Current: $0.87
Upside: +82.66%
Feb 17, 2026
Downgraded: Hold
Price Target: $3.85 → $2.40
Current: $2.38
Upside: +0.84%
Feb 2, 2026
Maintained: Buy
Price Target: $0.07 → $0.06
Current: $0.00
Upside: +1,400.00%
Nov 18, 2025
Maintained: Buy
Price Target: $350.00
Current: $162.21
Upside: +115.77%
Nov 7, 2025
Maintained: Buy
Price Target: $0.85 → $0.80
Current: $0.30
Upside: +171.19%
Oct 3, 2025
Maintained: Hold
Price Target: $37.00
Current: $44.34
Upside: -16.55%
Sep 24, 2025
Maintained: Buy
Price Target: $32.84
Current: $9.06
Upside: +262.47%
Sep 11, 2025
Maintained: Buy
Price Target: $3.00 → $2.81
Current: $0.29
Upside: +868.97%
Sep 10, 2025
Maintained: Buy
Price Target: $1.20
Current: $0.05
Upside: +2,508.70%
Sep 2, 2025
Maintained: Buy
Price Target: $3.00
Current: $1.70
Upside: +76.47%
Aug 28, 2025
Maintained: Buy
Price Target: $26.50
Current: $18.00
Upside: +47.22%
Aug 8, 2025
Maintained: Buy
Price Target: $8.50
Current: $2.37
Upside: +258.65%
Mar 24, 2025
Maintained: Hold
Price Target: $1.00
Current: $0.01
Upside: n/a
Feb 27, 2025
Downgraded: Hold
Price Target: $5.95 → $7.40
Current: $2.66
Upside: n/a
Feb 21, 2023
Maintained: Hold
Price Target: $0.71 → $0.55
Current: $0.41
Upside: n/a
Sep 2, 2022
Downgraded: Hold
Price Target: $0.17 → $0.06
Current: $1.16
Upside: n/a
Aug 29, 2022
Maintained: Hold
Price Target: $0.50 → $0.55
Current: $0.10
Upside: n/a
Jun 1, 2022
Maintained: Buy
Price Target: $0.75
Current: $0.01
Upside: n/a